Home
>
National Drug Code (NDC)
>
PRIMAXIN
PRIMAXIN - 0006-3514-58 - (imipenem and cilastatin sodium)
Drug Information of PRIMAXIN
| Product NDC: | 0006-3514 |
| Proprietary Name: | PRIMAXIN |
| Non Proprietary Name: | imipenem and cilastatin sodium |
| Active Ingredient(s): | 250; 250 mg/100mL; mg/100mL & nbsp; imipenem and cilastatin sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PRIMAXIN
| Product NDC: | 0006-3514 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050587 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19851126 |
Package Information of PRIMAXIN
| Package NDC: | 0006-3514-58 |
| Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0006-3514-58) > 100 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of PRIMAXIN
| NDC Code | 0006-3514-58 |
| Proprietary Name | PRIMAXIN |
| Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0006-3514-58) > 100 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0006-3514 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | imipenem and cilastatin sodium |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19851126 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | CILASTATIN SODIUM; IMIPENEM |
| Strength Number | 250; 250 |
| Strength Unit | mg/100mL; mg/100mL |
| Pharmaceutical Classes | Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC] |
